Pacira BioSciences, Inc. Quarterly Depreciation in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Pacira BioSciences, Inc. quarterly/annual Depreciation history and growth rate from Q2 2011 to Q3 2024.
  • Pacira BioSciences, Inc. Depreciation for the quarter ending September 30, 2024 was $6M, a 46.3% increase year-over-year.
  • Pacira BioSciences, Inc. Depreciation for the twelve months ending September 30, 2024 was $18.8M, a 38% decline year-over-year.
  • Pacira BioSciences, Inc. annual Depreciation for 2023 was $18.3M, a 46.5% decline from 2022.
  • Pacira BioSciences, Inc. annual Depreciation for 2022 was $34.2M, a 128% increase from 2021.
  • Pacira BioSciences, Inc. annual Depreciation for 2021 was $15M, a 25% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $18.8M $6M +$1.9M +46.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $16.9M $4.5M -$200K -4.26% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $17.1M $4.1M -$1.2M -22.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $18.3M $4.2M -$12M -74.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $30.3M $4.1M -$1.7M -29.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $32M $4.7M -$1.8M -27.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $33.8M $5.3M -$400K -7.02% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $34.2M $16.2M +$10.8M +200% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $23.4M $5.8M +$2M +52.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $21.4M $6.5M +$3.6M +124% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $17.8M $5.7M +$2.8M +96.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q4 2021 $15M $5.4M +$2.4M +80% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $12.6M $3.8M +$700K +22.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $11.9M $2.9M -$100K -3.33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $12M $2.9M $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $12M $3M -$300K -9.09% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $12.3M $3.1M -$500K -13.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $12.8M $3M -$500K -14.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $13.3M $2.9M -$700K -19.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $14M $3.3M -$800K -19.5% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $14.8M $3.6M +$100K +2.86% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $14.7M $3.5M +$700K +25% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $14M $3.6M +$800K +28.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $13.2M $4.1M +$500K +13.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $12.7M $3.5M +$100K +2.94% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $12.6M $2.8M -$900K -24.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $13.5M $2.8M -$300K -9.68% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $13.8M $3.6M -$2.6M -41.9% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $16.4M $3.4M +$100K +3.03% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $16.3M $3.7M +$500K +15.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 $15.8M $3.1M +$3M +3000% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 $12.8M $6.2M +$3.2M +107% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $9.6M $3.3M +$500K +17.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $9.1M $3.2M +$500K +18.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $8.6M $100K -$2.6M -96.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $11.2M $3M -$6.3M -67.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $17.5M $2.8M +$500K +21.7% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $17M $2.7M +$400K +17.4% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 $16.6M $2.7M +$600K +28.6% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $16M $9.3M +$8.1M +675% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $7.9M $2.3M +$1.5M +188% Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-27
Q2 2014 $6.4M $2.3M +$1.5M +188% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-30
Q1 2014 $4.9M $2.1M +$1.2M +133% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-30
Q4 2013 $3.7M $1.2M +$300K +33.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-25
Q3 2013 $3.4M $800K -$100K -11.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-30
Q2 2013 $3.5M $800K -$100K -11.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $3.6M $900K $0 0% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 $3.6M $900K Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 $900K +$400K +80% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-31
Q2 2012 $900K +$500K +125% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $900K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q3 2011 $500K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-01
Q2 2011 $400K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.